4-(5,6-dihydrothieno[2,3-h]quinazolin-2-ylamino)-N-(3-(dimethylamino)propyl)benzenesulfonamide

ID: ALA1085308

PubChem CID: 46890388

Max Phase: Preclinical

Molecular Formula: C21H25N5O2S2

Molecular Weight: 443.60

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(C)CCCNS(=O)(=O)c1ccc(Nc2ncc3c(n2)-c2ccsc2CC3)cc1

Standard InChI:  InChI=1S/C21H25N5O2S2/c1-26(2)12-3-11-23-30(27,28)17-7-5-16(6-8-17)24-21-22-14-15-4-9-19-18(10-13-29-19)20(15)25-21/h5-8,10,13-14,23H,3-4,9,11-12H2,1-2H3,(H,22,24,25)

Standard InChI Key:  QXKCVFCSUZQYJJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   15.0500   -9.8333    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4667  -10.5500    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   15.8790   -9.8308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.1872  -12.2110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.9037  -11.7977    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9008  -10.9672    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.1854  -10.5580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6188  -12.2091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.3326  -11.7954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0444  -12.2073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7577  -11.7943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7569  -10.9684    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0367  -10.5572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3263  -10.9725    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1858  -10.9643    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4602  -12.4818    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.8693  -13.1970    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6758  -13.0288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4771  -11.8030    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4816  -10.9758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7714  -10.5606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0522  -10.9680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0477  -11.7953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7624  -12.2151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8999  -10.5511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6147  -10.9630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3288  -10.5498    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0437  -10.9617    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7578  -10.5485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0444  -11.7867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12  2  1  0
  7 20  1  0
  2 15  1  0
 19  4  1  0
  5  8  1  0
  2  1  2  0
 23 16  1  0
 16 17  1  0
 17 18  2  0
 18 24  1  0
 19 20  2  0
  8  9  1  0
  4  5  2  0
  9 10  2  0
  3  2  2  0
 10 11  1  0
  5  6  1  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  2  0
 11 12  2  0
 15 25  1  0
 25 26  1  0
 12 13  1  0
 26 27  1  0
  6  7  2  0
 27 28  1  0
 13 14  2  0
 28 29  1  0
 14  9  1  0
 28 30  1  0
M  END

Associated Targets(Human)

IKBKB Tchem Inhibitor of nuclear factor kappa B kinase beta subunit (5554 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LoVo (4724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 443.60Molecular Weight (Monoisotopic): 443.1450AlogP: 3.28#Rotatable Bonds: 8
Polar Surface Area: 87.22Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.66CX Basic pKa: 9.28CX LogP: 3.43CX LogD: 1.70
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.52Np Likeness Score: -1.79

References

1. Crombie AL, Sum FW, Powell DW, Hopper DW, Torres N, Berger DM, Zhang Y, Gavriil M, Sadler TM, Arndt K..  (2010)  Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors.,  20  (12): [PMID:20471256] [10.1016/j.bmcl.2010.04.022]

Source